Literature DB >> 23990281

Illness perceptions, risk perception and worry in SDH mutation carriers.

L T van Hulsteijn1, A A Kaptein, A Louisse, N R Biermasz, J W A Smit, E P M Corssmit.   

Abstract

Succinate dehydrogenase (SDH) mutation carriers are predisposed for developing paragangliomas. This study aimed to explore illness perceptions, risk perception and disease-related worry in these individuals. All consecutive SDHB and SDHD mutation carriers followed at the Department of Endocrinology of the Leiden University Medical Center (LUMC), a tertiary referral center, were eligible for inclusion. Illness perceptions were assessed using the validated Illness Perception Questionnaire-Revised and compared to reference populations. Risk perception and worry were measured by two items each and associations with illness perceptions explored. Twenty SDHB and 118 SDHD mutation carriers responded. Compared with various reference groups, SDH mutation carriers perceived less controllability of their condition. SDHB mutation carriers considered their condition to be less chronic in nature (p = 0.005) and perceived more personal (p = 0.018) and treatment control (p = 0.001) than SDHD mutation carriers. Mutation carriers with manifest disease reported more negative illness perceptions and a higher risk perception of developing subsequent tumors than asymptomatic mutation carriers. Illness perceptions, risk perception and disease-related worry were strongly correlated. Risk perception and disease-related worry may be assessed through illness perceptions. The development of interventions targeting illness perceptions may provide tools for genetic counseling.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23990281     DOI: 10.1007/s10689-013-9680-5

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  27 in total

1.  Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas.

Authors:  Henri J L M Timmers; Anna Kozupa; Graeme Eisenhofer; Margarita Raygada; Karen T Adams; Daniel Solis; Jacques W M Lenders; Karel Pacak
Journal:  J Clin Endocrinol Metab       Date:  2007-01-02       Impact factor: 5.958

2.  Affected illness perceptions and the association with impaired quality of life in patients with long-term remission of acromegaly.

Authors:  Jitske Tiemensma; Adrian A Kaptein; Alberto M Pereira; Johannes W A Smit; Johannes A Romijn; Nienke R Biermasz
Journal:  J Clin Endocrinol Metab       Date:  2011-09-14       Impact factor: 5.958

3.  Mutations in SDHD are the major determinants of the clinical characteristics of Dutch head and neck paraganglioma patients.

Authors:  E F Hensen; M D Siemers; J C Jansen; E P M Corssmit; J A Romijn; C M J Tops; A G L van der Mey; P Devilee; C J Cornelisse; J P Bayley; A H J T Vriends
Journal:  Clin Endocrinol (Oxf)       Date:  2011-11       Impact factor: 3.478

4.  A multicenter review of carotid body tumour management.

Authors:  M S Sajid; G Hamilton; D M Baker
Journal:  Eur J Vasc Endovasc Surg       Date:  2007-04-02       Impact factor: 7.069

5.  Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.

Authors:  Diana E Benn; Anne-Paule Gimenez-Roqueplo; Jennifer R Reilly; Jérôme Bertherat; John Burgess; Karen Byth; Michael Croxson; Patricia L M Dahia; Marianne Elston; Oliver Gimm; David Henley; Philippe Herman; Victoria Murday; Patricia Niccoli-Sire; Janice L Pasieka; Vincent Rohmer; Kathy Tucker; Xavier Jeunemaitre; Deborah J Marsh; Pierre-François Plouin; Bruce G Robinson
Journal:  J Clin Endocrinol Metab       Date:  2005-11-29       Impact factor: 5.958

6.  Subjective and objective risk of ovarian cancer in Ashkenazi Jewish women testing for BRCA1/2 mutations.

Authors:  Kimberly M Kelly; Leigha Senter; Howard Leventhal; Gozde Ozakinci; Kyle Porter
Journal:  Patient Educ Couns       Date:  2007-11-07

7.  Subjective versus objective risk in genetic counseling for hereditary breast and/or ovarian cancers.

Authors:  Anita Caruso; Cristina Vigna; Bruna Marozzo; Fabio M Sega; Isabella Sperduti; Francesco Cognetti; Antonella Savarese
Journal:  J Exp Clin Cancer Res       Date:  2009-12-21

8.  Further development of an illness perception intervention for myocardial infarction patients: a randomized controlled trial.

Authors:  Elizabeth Broadbent; Chris J Ellis; Janine Thomas; Greg Gamble; Keith J Petrie
Journal:  J Psychosom Res       Date:  2009-03-04       Impact factor: 3.006

9.  Conservative treatment of vestibular schwannoma: a follow-up study on clinical and quality-of-life outcome.

Authors:  Willem P Godefroy; Adrian A Kaptein; Justine J Vogel; Andel G L van der Mey
Journal:  Otol Neurotol       Date:  2009-10       Impact factor: 2.311

10.  Illness perceptions, coping, and quality of life in vestibular schwannoma patients at diagnosis.

Authors:  Justine J Vogel; Willem P Godefroy; Andel G L van der Mey; Saskia le Cessie; Adrian A Kaptein
Journal:  Otol Neurotol       Date:  2008-09       Impact factor: 2.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.